Jose Castro-Perez received his Bachelor of Science in Chemistry from King’s College in London (United Kingdom) and subsequently received his Master of Science in Clinical Biochemistry and Molecular Biology from the University of Surrey (United Kingdom). Further post-graduate study concluded in obtaining his Ph.D. (Dynamic System-Wide Mass Spectrometry based Metabolomics Approach for a New Era in Drug Research) at the University of Leiden (The Netherlands).He has more than 25 years’ experience in Bioanalysis. During his early career years, he worked at Huntingdon Life Sciences (United Kingdom) Contract Research Organization as a senior LC/MS-MS research scientist in DMPK Bioanalysis where he managed the analysis of Phase II and III clinical trials samples in the laboratory using LC/MS-MS and enzyme immunoassays. Following his tenure at Huntingdon Life Sciences, he held various bioanalytical leadership positions at Merck , Waters Corporation and Agios Pharmaceuticals supporting Target ID/Validation, DMPK, Biomarker Discovery/Development, and Translational Clinical Research. Currently, he is responsible for Global Market Development at SCIEX.He is passionate about science and holds a strong commitment to improving the quality of life of patients.His scientific curiosity has led to extensive publications in peer-reviewed scientific journals with a total of 71 publications including two book chapter in drug metabolism and 3 patent applications.